SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is currently a focal point for retail investors and the WallStreetBets community, who are actively discussing a potential short squeeze fueled by significant short interest and speculation regarding a possible buyout. The conversation is further amplified by excitement over new leadership appointments, international expansion plans, and a high dividend yield that has attracted value-focused investors looking for a turnaround story.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is experiencing intense volatility as investors react to a sharp semiconductor-led selloff and uncertainty ahead of Micron's upcoming earnings report. The community is actively debating whether this pullback represents a healthy market correction or a structural breakdown in the AI-driven rally, with many traders closely monitoring South Korean market trends for further signals.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is gaining significant community attention as investors anticipate the Phase 3 REGAL trial data and a potential buyout, driving intense discussions around institutional accumulation and extreme short-squeeze conditions. The stock is trending due to the combination of near-zero share availability for shorting and high borrowing costs, fueling retail enthusiasm as participants watch for a pivotal trial milestone.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras Systems is trending as investors weigh its aggressive growth potential against significant valuation concerns and near-term risks, including upcoming insider share lockup expirations. While the community actively debates whether the company can successfully challenge current AI hardware leaders, sentiment remains split between those betting on long-term technological adoption and others skeptical of current price-to-sales ratios.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail and institutional investors anticipate significant buying pressure from the company's expected inclusion in the Russell 1000 index. The community is actively discussing this milestone as a potential catalyst for long-term growth while debating the impact of upcoming global expansion announcements and the ongoing influence of the biotech regulatory landscape on the stock's future.

Backblaze, Inc. operates as a cloud provider for businesses and consumers to store, use, and protect their data. The firm, through its storage cloud platform, provides a foundation for businesses, developers, IT professionals, and individuals to store, backup, and archive data, host content, manage media, and build their applications. It also offers B2 Cloud Storage and Computer Backup services. The company was founded by Timothy Nufire, Gleb Budman, Charles Jones, Kwok Hang Ng and Brian Wilson in 2007 and is headquartered in San Francisco, CA.

Backblaze Inc - Ordinary Shares - Class A

Backblaze is seeing a surge in investor attention following a major five-year, $335 million storage contract with CoreWeave that significantly bolsters its AI infrastructure profile. Community members are actively debating the long-term revenue impact of the deal, with many focused on whether this partnership signals a structural re-rating of the company's valuation as it integrates into the AI supply chain.

FedEx Corp. is a holding company, which engages in the provision of transportation, e-commerce, business services, and business solutions. It operates through the following segments: FedEx Express, FedEx Freight, Corporate, Other, and Eliminations. The FedEx Express segment offers transportation and delivery services. The FedEx Freight segment refers to freight transportation services to business and residences. The FedEx Services segment includes sales, marketing, information technology, communications, customer service, technical support, billing and collection services, and certain back-office functions that support the company's operating segments. The Corporate, Other, and Eliminations segment is involved in the corporate headquarters costs for executive officers and certain legal and finance functions, as well as certain other costs and credits not attributed to the firm's core business. The company was founded by Frederick Wallace Smith on June 18, 1971, and is headquartered in Memphis, TN.

Fedex Corp

FedEx is currently seeing significant market activity and community debate as investors react to its latest earnings report, which featured a notable revenue and EPS beat alongside an upward revision to its full-year guidance. While some traders are bullish on the company's cost-cutting transformation and efficient operations, others are expressing concern over the potential impact of volatile energy costs and the broader implications of Amazon's expanding logistics network on future parcel demand.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing high volatility as investors weigh a major earnings report against concerns about semiconductor sector leverage and recent pullbacks in global chip markets. The community remains deeply divided, with bulls pointing to strong AI-driven memory demand and institutional price target hikes, while bears express caution over stretched valuations and historical post-earnings sell-offs.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is trending after a $700 million upsized public offering, sparking intense debate among investors regarding the company's long-term growth versus the impact of immediate share dilution. While some community members view the successful capital raise as an institutional vote of confidence in the company's positive Phase 3 clinical data, others remain skeptical, citing historical management controversies and potential downward pressure from the expanded float.

Invesco DB US Dollar Index Bullish Fund - Invesco DB US Dollar Index Bullish Fund

Invesco DB US Dollar Index Bullish Fund

The UUP fund is experiencing significant attention as traders navigate the dollar's strength, fueled by ongoing geopolitical tensions in the Middle East and concerns over persistent inflation. Investors are closely monitoring how the Federal Reserve's hawkish stance and the evolving macro landscape are driving institutional capital shifts and impacting the dollar's performance relative to other major global currencies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

PFCBP.F. Chang's China Bistro, Inc.

Latest PFCB News